Bladder instillation without triamcinolone acetonide (DrugBank: Triamcinolone)
8 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
35 | Pemphigus | 0 |
46 | Malignant rheumatoid arthritis | 0 |
56 | Behcet disease | 0 |
70 | Spinal stenosis | 0 |
90 | Retinitis pigmentosa | 0 |
96 | Crohn disease | 0 |
226 | Interstitial cystitis with Hunners ulcer | 1 |
298 | Hereditary pancreatitis | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03463915 (ClinicalTrials.gov) | January 25, 2019 | 28/2/2018 | Clinical Trial Comparing Two Bladder Instillations for IC/BPS | Randomized Controlled Trial Comparing Two Different Bladder Instillation Treatments for Interstitial Cystitis/Bladder Pain Syndrome | Interstitial Cystitis;Bladder Pain Syndrome | Drug: Bladder instillation WITH triamcinolone acetonide;Drug: Bladder instillation WITHOUT triamcinolone acetonide | Olivia Cardenas-Trowers, M.D. | NULL | Completed | 18 Years | N/A | Female | 90 | Phase 3 | United States |